Revenue: The sum of all revenue fields included for a company's operating activities.
Aurinia Pharmaceuticals Inc (AUPH) had Revenue of $235.13M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$235.13M |
$5.75M |
|
$28.25M |
|
$206.88M |
|
$244.17M |
|
$-9.03M |
|
$16.48M |
|
$7.45M |
|
$7.45M |
|
$5.75M |
|
$5.75M |
|
$5.75M |
|
$5.75M |
|
$-9.03M |
|
$10.41M |
|
143.06M |
|
146.19M |
|
$0.04 |
|
$0.04 |
|
| Balance Sheet Financials | |
$446.60M |
|
$2.73M |
|
$104.05M |
|
$550.64M |
|
$97.76M |
|
$58.55M |
|
$75.40M |
|
$173.17M |
|
$377.48M |
|
$373.12M |
|
$377.48M |
|
140.88M |
|
| Cash Flow Statement Financials | |
$44.39M |
|
$39.26M |
|
$-49.09M |
|
$48.88M |
|
$83.43M |
|
$34.56M |
|
$31.60M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.57 |
|
-- |
|
-- |
|
0.13 |
|
0.19 |
|
87.99% |
|
-3.84% |
|
-3.84% |
|
4.43% |
|
3.17% |
|
2.45% |
|
$44.11M |
|
-- |
|
-- |
|
-- |
|
0.43 |
|
0.72 |
|
6.43 |
|
56.73 |
|
1.52% |
|
1.54% |
|
1.04% |
|
1.32% |
|
$2.68 |
|
$0.30 |
|
$0.30 |
|